Wealth Quarterback’s Aevi Genomic Medicine Inc GNMX Stock Holding History

Wealth Quarterback’s Portfolio GNMX Stock Details GNMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-70	Closed	-$10	–	1169
2019 Q4	$10	Buy	+70	New	+$10	﹤0.01%	1038

Wealth Quarterback's GNMX Position: Q1 2020 in Review

Wealth Quarterback sold out of Aevi Genomic Medicine Inc (GNMX) in Q1 2020, closing a stake of 70 shares — an estimated $10 sold.

Wealth Quarterback first reported a position in GNMX in Q4 2019 and held it in 1 quarter. The position peaked at $10 in Q4 2019. 2 funds tracked by Wall St. Rank hold GNMX as of Q1 2020.

Wealth Quarterback reported no remaining Aevi Genomic Medicine Inc position as of Q1 2020 after selling out during the quarter.
Wealth Quarterback sold 70 Aevi Genomic Medicine Inc shares in Q1 2020, an estimated $10.
Wealth Quarterback first reported a position in Aevi Genomic Medicine Inc in Q4 2019 and held it in 1 quarter.
Wealth Quarterback's Aevi Genomic Medicine Inc position peaked at $10 in Q4 2019.
2 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q1 2020.

Based on Wealth Quarterback's 13F filing for Q1 2020, filed 14 May 2020.